Cabergoline Research Compound Overview
Cabgolin 0.25 mg is a pharmaceutical-grade cabergoline preparation manufactured by Sun Pharmaceuticals Industries. Cabergoline is a dopamine receptor agonist compound classified as an ergot derivative, specifically targeting D2 dopamine receptors. This formulation provides researchers with access to a standardised cabergoline preparation for investigating dopamine pathway modulation in laboratory settings. Each tablet contains 0.25 mg of active cabergoline compound, enabling precise research protocols. The pharmaceutical manufacturing standards ensure consistent potency and purity for reliable experimental outcomes. Researchers examining post-cycle therapy mechanisms frequently investigate cabergoline’s interaction with prolactin regulation pathways in cellular models.
Laboratory Research Applications
Cabergoline research spans multiple endocrine and neurological investigation areas. Scientists study its dopamine D2 receptor agonist properties to understand prolactin secretion inhibition mechanisms in pituitary cell cultures. The compound demonstrates high binding affinity for dopamine receptors, making it valuable for examining neurotransmitter pathway modulation. Researchers at Stroid UK Shop investigate cabergoline’s role in hormonal feedback systems and its potential applications in endocrine research. Studies examine the compound’s long half-life properties and sustained dopamine receptor activation patterns. Post cycle therapy research protocols frequently incorporate cabergoline studies to evaluate prolactin suppression mechanisms. Comparative studies with SARMs examine hormonal recovery pathways, while peptides research investigates synergistic endocrine modulation effects in controlled laboratory environments.
Product Specifications
| Parameter | Value |
|---|---|
| Active Compound | Cabergoline |
| Concentration | 0.25 mg per tablet |
| Manufacturer | Sun Pharmaceuticals Industries |
| Form | Oral tablets |
| CAS Number | 81409-90-7 |
| Molecular Formula | C₂₆H₃₇N₅O₂ |
| Storage | Room temperature, dry conditions |
Research Use Compliance
Cabgolin 0.25 mg Sun Pharmaceuticals is supplied exclusively for in-vitro research and laboratory analysis purposes. This product is not approved for human consumption, clinical use, or therapeutic applications. Researchers must maintain appropriate laboratory safety protocols and comply with institutional research guidelines when handling this compound. The product is intended solely for qualified researchers conducting legitimate scientific investigations into cabergoline’s biochemical properties and mechanisms of action.
